oral glp-1 meds Wegovy Pill Becomes First Weight-Loss Drug Approved in U.S Clinically backed oral GLP Dry Mouth Relief for GLP-1

Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis

This does make sense to me though, given that the GLP-1s may tangle with our systems of reward, etc

During dose-optimization, subjects assigned to VYVANSE began treatment at the titration dose of 30 mg/day and, after 1 week of treatment, were subsequently titrated to 50 mg/day

Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H

These findings are promising for future research in the fields of anti-aging, stunted growth, injury recovery, and womens health as women are at an increased risk of poor bone density as they age

J., Rijkers, D